The agency said that a review of some studies showed that the drugs’ potential benefits in treating Covid-19 did not outweigh the risks.
Author: Katie Thomas
Coronavirus Patients in Limbo as Gilead Suspends Emergency Drug Access
The company says it will switch to a broader approach for its experimental drug, remdesivir. But it was overwhelmed by demand for a potential treatment promoted by President Trump.
As Coronavirus Testing Increases, Some Labs Fear a Shortage of Other Supplies
Lab directors and federal officials are keeping a close eye on the supply of other materials needed to conduct the tests.